Roche Forays in Rare Diseases by Licensing PTC Therapeutics’ Spinal Muscular Atrophy Programme |
Abstract
|
Heather Cartwright |
|
Servier Options MacroGenics’ Phase I Cancer Immunotherapy |
Abstract
|
Heather Cartwright |
|
India’s Lupin Expands its Presence In Japan with I’rom Pharmaceutical Acquisition |
Abstract
|
Heather Cartwright |
|
Gilead Bets on Pharmasset with US$11 B Acquisition Agreement |
Abstract
|
Heather Cartwright |
|
Pfizer Gains Phase II Skin Fibrosis Drug with Excaliard Acquisition |
Abstract
|
Heather Cartwright |
|
AstraZeneca Strengthens its Position in China with Guangdong BeiKang Pharmaceutical Acquisition |
Abstract
|
Heather Cartwright |
|
Biogen Idec Enters Biosimilars Market via Joint Venture with Samsung Biologics |
Abstract
|
Heather Cartwright |
|